Table 1.
Demographic and clinical characteristics of patients
| All patients (n=3,447) |
Men (n=2,822) |
Women (n=625) |
P-value | |
|---|---|---|---|---|
| Median age (IQR) (years) | 59 (52–68) | 58 (51–66) | 66 (57–73) | 0.001 |
| ACS type | ||||
| NSTEACS (%) | 48.7 | 46.3 | 59.7 | 0.001 |
| STEMI (%) | 51.3 | 53.7 | 40.3 | 0.001 |
| BMI (IQR) (kg/m2) | 27 (24.9–29.2) | 27 (25.1–29.3) | 27.1 (24.3–29.2) | 0.001 |
| BMI ≤24.9 kg/m2 (%) | 25.8 | 23.9 | 34.1 | 0.001 |
| BMI 25–29.9 kg/m2 (%) | 54.1 | 55.9 | 46.2 | 0.001 |
| BMI ≥30 kg/m2 (%) | 20.1 | 20.2 | 19.7 | 0.77 |
| Medical history | ||||
| Prior MI (%) | 28.7 | 29.1 | 27.0 | 0.29 |
| Prior PCI (%) | 14.3 | 15.0 | 10.9 | 0.007 |
| Prior CABG (%) | 4.2 | 4.3 | 3.8 | 0.61 |
| Renal dysfunction* (%) | 5.1 | 4.9 | 6.1 | 0.22 |
| Previous statin therapy (%) | 28.3 | 28.1 | 29.1 | 0.62 |
| Familial history of CAD (%) | 10.3 | 10.9 | 10.2 | 0.59 |
| Disease extent | ||||
| One-vessel disease (%) | 41.1 | 41.5 | 39.4 | 0.33 |
| Two-vessel disease (%) | 29.5 | 29.8 | 28.3 | 0.47 |
| Three-vessel disease (%) | 29.4 | 28.8 | 32.3 | 0.07 |
Notes:
*
Creatinine was ≥2 mg or creatinine depuration was ≤30 mL/minute at the time of admission.
Abbreviations: ACS, acute coronary syndrome; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; IQR, interquartile range; MI, myocardial infarction; NSTEACS, non–ST-elevation acute coronary syndrome; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.